Concepedia

Minsheng He

MH

Statistics

Publications

3

Citations

72

H-Index

3

Active since

2021

Affiliations

C4 Therapeutics (United States)(Current)

Minsheng He is an author at C4 Therapeutics (United States) specializing in medicine, systems biology, and bioinformatics.

Top concepts

Publications per year

2021–2023

3

Publications

3

Abstract ND09: The discovery and characterization of CFT8634: A potent and selective degrader of BRD9 for the treatment of SMARCB1-perturbed cancers

Katrina L. Jackson, Roman V. Agafonov, Mark W. Carlson et al. · Cancer Research · 2022 · 37 citations

, , +20

Development of an AchillesTAG degradation system and its application to control CAR-T activity

Gesine K. Veits, Christina S. Henderson, Abigail Vogelaar et al. · Current Research in Chemical Biology · 2021 · 20 citations · Full text

, , +16

CFT8634, a Clinical Stage BRD9 Bi DAC™ Degrader, Is Active in a Subset of Multiple Myeloma Cell Line Models and Synergistic When Combined with Pomalidomide

Laura L. Poling, David Cocozziello, Minsheng He et al. · Blood · 2023 · 15 citations

1–3 of 3